MB

MPM BioImpact Portfolio holdings

AUM $611M
1-Year Est. Return 29.61%
This Quarter Est. Return
1 Year Est. Return
+29.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$622M
AUM Growth
+$195M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
44
New
Increased
Reduced
Closed

Top Buys

1
+$23.9M
2
+$23.1M
3
+$15.8M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$11.5M
5
ETNB
89bio
ETNB
+$11.3M

Top Sells

1
+$16.9M
2
+$16.1M
3
+$14.4M
4
VKTX icon
Viking Therapeutics
VKTX
+$14.4M
5
GPCR icon
Structure Therapeutics
GPCR
+$9.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$9.02M 1.45%
+760,722
27
$8.81M 1.42%
273,217
-191
28
$8.47M 1.36%
638,163
29
$8.47M 1.36%
718,970
+3,087
30
$8.41M 1.35%
+332,924
31
$8.05M 1.29%
5,095,912
32
$8.05M 1.29%
+441,259
33
$7.72M 1.24%
1,639,849
34
$6.91M 1.11%
832,017
35
$6.9M 1.11%
110,779
+60,779
36
$4.63M 0.74%
+1,340,960
37
$4.15M 0.67%
+395,237
38
$3.9M 0.63%
+1,971,402
39
– –
-230,696
40
– –
-323,813
41
– –
-70,000
42
– –
-611,181
43
– –
-53,279
44
– –
-319,670
1
2